BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7959906)

  • 1. Effects of 1,25-dihydroxyvitamin D3 and the analogues MC903 and KH1060 on interleukin-1 beta-induced inhibition of rat pancreatic islet beta-cell function in vitro.
    Sandler S; Buschard K; Bendtzen K
    Immunol Lett; 1994 Jun; 41(1):73-7. PubMed ID: 7959906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-methyl-L-thiocitrulline counteracts interleukin 1 beta induced suppression of pancreatic islet function in vitro, but does not protect against multiple low-dose streptozotocin-induced diabetes in vivo.
    Sternesjö J; Welsh N; Sandler S
    Cytokine; 1997 May; 9(5):352-9. PubMed ID: 9195135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion.
    Lee S; Clark SA; Gill RK; Christakos S
    Endocrinology; 1994 Apr; 134(4):1602-10. PubMed ID: 8137721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanisms causing inhibition of insulin secretion in rat pancreatic islets exposed to human interleukin-1 beta indicate a perturbation in the mitochondrial function.
    Sandler S; Bendtzen K; Borg LA; Eizirik DL; Strandell E; Welsh N
    Endocrinology; 1989 Mar; 124(3):1492-501. PubMed ID: 2521822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone prevents interleukin-1beta-mediated inhibition of rat islet insulin secretion without decreasing nitric oxide production.
    Mauricio D; Andersen HU; Larsen CM; Karlsen AE; Mandrup-Poulsen T; Nerup J
    Cytokine; 1997 Aug; 9(8):563-9. PubMed ID: 9245483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-6 affects insulin secretion and glucose metabolism of rat pancreatic islets in vitro.
    Sandler S; Bendtzen K; Eizirik DL; Welsh M
    Endocrinology; 1990 Feb; 126(2):1288-94. PubMed ID: 2404746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of interleukin-12 in vitro on pancreatic islets isolated from normal rodents and from non-obese diabetic mice.
    Sternesjö J; Sandler S
    J Endocrinol; 1998 Jul; 158(1):69-75. PubMed ID: 9713328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 4 impairs rat pancreatic islet function in vitro by an action different to that of interleukin 1.
    Sandler S; Sternesjö J
    Cytokine; 1995 Apr; 7(3):296-300. PubMed ID: 7640349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-13 counteracts suppression induced by interleukin-1beta of glucose metabolism but not of insulin secretion in rat pancreatic islets.
    Sternesjö J; Sandler S
    Autoimmunity; 1997; 26(3):153-9. PubMed ID: 9550283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of 1400 W, a novel inhibitor of inducible nitric oxide synthase, in preventing interleukin-1beta-induced suppression of pancreatic islet function in vitro and multiple low-dose streptozotocin-induced diabetes in vivo.
    Rydgren T; Sandler S
    Eur J Endocrinol; 2002 Oct; 147(4):543-51. PubMed ID: 12370118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between calbindin-D28K levels in the A and B cells of the rat endocrine pancreas and the secretion of insulin and glucagon: influence of vitamin D3 deficiency and 1,25-dihydroxyvitamin D3.
    Bourlon PM; Faure-Dussert A; Billaudel B; Sutter BC; Tramu G; Thomasset M
    J Endocrinol; 1996 Feb; 148(2):223-32. PubMed ID: 8699136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase.
    Corbett JA; McDaniel ML
    Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):719-24. PubMed ID: 7514870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of molecular pathways mediating 1,25-dihydroxyvitamin D3 protection against cytokine-induced inflammation and damage of human and male mouse islets of Langerhans.
    Wolden-Kirk H; Rondas D; Bugliani M; Korf H; Van Lommel L; Brusgaard K; Christesen HT; Schuit F; Proost P; Masini M; Marchetti P; Eizirik DL; Overbergh L; Mathieu C
    Endocrinology; 2014 Mar; 155(3):736-47. PubMed ID: 24424042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective action by hemin against interleukin-1 beta induced inhibition of rat pancreatic islet function.
    Welsh N; Sandler S
    Mol Cell Endocrinol; 1994 Jul; 103(1-2):109-14. PubMed ID: 7958387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low extracellular calcium enhances beta cell sensitivity to the stimulatory influence of 1,25-dihydroxyvitamin D3 on insulin release by islets from vitamin D3-deficient rats.
    Faure-Dussert AG; Delbancut AP; Billaudel BJ
    Steroids; 1997 Jul; 62(7):554-62. PubMed ID: 9253796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism and beta-cell function of rat pancreatic islets exposed to human interleukin-1 beta in the presence of a high glucose concentration.
    Sandler S; Bendtzen K; Eizirik DL; Strandell E; Welsh M; Welsh N
    Immunol Lett; 1990 Dec; 26(3):245-51. PubMed ID: 2086453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominance of stimulatory effects of interleukin-1 beta on isolated human pancreatic islets.
    Eizirik DL; Welsh N; Hellerström C
    J Clin Endocrinol Metab; 1993 Feb; 76(2):399-403. PubMed ID: 8432782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lisofylline, an inhibitor of unsaturated phosphatidic acid generation, ameliorates interleukin-1 beta-induced dysfunction in cultured rat islets.
    Bleich D; Chen S; Bursten SL; Nadler JL
    Endocrinology; 1996 Nov; 137(11):4871-7. PubMed ID: 8895359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta.
    Eizirik DL; Sandler S; Hallberg A; Bendtzen K; Sener A; Malaisse WJ
    Endocrinology; 1989 Aug; 125(2):752-9. PubMed ID: 2666106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
    Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
    Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.